子宫内膜异位症对抗穆勒尔激素的影响
Yun Soo Chung1, Euna Choi1, Jin Kyung Baek1
1Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Journal of clinical medicine
|July 12, 2025
概括
患有子宫内膜异位症的女性,特别是20-31岁的女性,表现出比对照组更高的抗米勒尔激素 (AMH) 水平. 这项研究表明,子宫内膜异位症可能不会在所有年龄组显著降低卵巢储备.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 妇科 妇科医生 妇科
背景情况:
- 子宫内膜异位症影响10%的生育年龄妇女,导致骨盆疼痛,经期不良和不孕.
- 高复发率往往需要多次手术,可能会影响卵巢储备.
- 子宫内膜瘤对卵巢组织体积的影响和主要原因 (子宫内膜异位症与子宫内膜异位瘤) 仍在争论中.
研究的目的:
- 为了调查是否患有子宫内膜异位症的女性在治疗前与健康卵巢的女性相比,抗米勒尔激素 (AMH) 水平较低.
- 评估子宫内膜异位症和卵巢储备标志物之间的关系.
主要方法:
- 研究了298名患有子宫内膜异位症的女性队列 (63人追溯,235人前).
- 测量和纠正抗米勒尔激素 (AMH) 水平,使用回归方程由于测定差异.
- 纠正的AMH水平与不同年龄组的参考值进行了比较,使用单样品t测试.
主要成果:
- 在子宫内膜异位症组中,抗穆勒尔激素 (AMH) 水平随年龄的增长而下降.
- 在20-31岁的年龄组 (n=168) 中,修正后的AMH高于 (5.96 ± 3.22 ng/mL) 的参考值 (4.94 ± 0.17 ng/mL,p < 0.01).
- 在35-37岁年龄组 (n=31) 中,校正的AMH (4.33 ± 3.06 ng/mL) 与参考值 (3.22 ± 0.15 ng/mL,p = 0.05) 相比.
- 在其他年龄组中没有发现显著差异.
结论:
- 患有子宫内膜异位症的患者,特别是年轻女性 (20-31岁),表现出比对照组更高的抗穆勒尔激素 (AMH) 水平.
- 在其他年龄组中没有观察到AMH水平的显著差异.
- 这些发现表明,子宫内膜异位症可能不会普遍导致卵巢储备减少.
相关概念视频
Oogenesis
64.4K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
64.4K
Hormonal Regulation of the Menstrual Cycle
708
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
708
Disorders of the Female Reproductive System
496
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
496
Menopause
252
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
252
Ovarian Cycle
1.9K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.9K


